Cooper Companies, Inc.
Close on Nov 20, 2026Market cap $11.20BP/E 20.1Yield –
Cooper Companies Completed Clinical Studies by Year
Completed Clinical Studies (by Start Fiscal Year)
Cooper Companies Completed Clinical Studies: 4 in FY2026, down 42.9% from a year earlier. That is the lowest of the 10 years on record here.
Where the FY2026 figure comes from
Source: U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Cooper Companies Completed Clinical Studies, annual FY2017–FY2026 [Data set]. Compiled from Cooper Companies SEC filings and investor materials. https://stockdatahq.com/stocks/coo/kpis/ct-completed-studies
See every metric in the Cooper Companies KPI table. Data updated Nov 18, 2026.
See a number that looks wrong?